(Q34498424)

English

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

2 August 2017

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage (English)

1 reference

stated in

Europe PubMed Central

2 August 2017

1 reference

1 reference

proliferative diabetic retinopathy

1 reference

1

Richard F Spaide

1 reference

stated in

Europe PubMed Central

2 August 2017

Yale L Fisher

2

1 reference

stated in

Europe PubMed Central

2 August 2017

1 March 2006

1 reference

stated in

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

26

1 reference

stated in

Europe PubMed Central

2 August 2017

275-278

1 reference

stated in

Europe PubMed Central

2 August 2017

3

1 reference

stated in

Europe PubMed Central

PubMed ID

16508426

retrieved

2 August 2017

Identifiers

DOI

10.1097/00006982-200603000-00004

1 reference

stated in

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

PubMed ID

16508426

retrieved

2 August 2017

(Q34498424)

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)